Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
China Everbright ( (HK:0165) ) has provided an update.
China Everbright Limited has amended the terms of a connected transaction involving one of its investment funds, with its wholly owned subsidiaries acting as general partner and a limited partner alongside Sun Life Everbright. The changes, agreed under a new supplemental agreement, adjust the fund’s life and fee mechanics while leaving the rest of the partnership terms intact.
Under the revised terms, the fund will now run for up to ten years from the initial closing date, with the general partner able to extend the term by one year unilaterally and by a further year with unanimous partner consent to facilitate an orderly exit from remaining investments. Management fees will be payable only for five years from each capital contribution date at 1% of each partner’s invested balance, with no fees charged during any extended term, which the board views as fair, commercially normal and in the interests of shareholders, with no director required to abstain from approval.
The most recent analyst rating on (HK:0165) stock is a Hold with a HK$10.00 price target. To see the full list of analyst forecasts on China Everbright stock, see the HK:0165 Stock Forecast page.
More about China Everbright
China Everbright Limited is a Hong Kong-incorporated investment holding company engaged in asset management and private equity, primarily operating through funds and specialized investment vehicles. The group focuses on managing third-party and proprietary capital across Greater China and related markets, often via limited partnership structures and wholly owned management subsidiaries.
Average Trading Volume: 7,921,411
Technical Sentiment Signal: Buy
Current Market Cap: HK$15.64B
See more data about 0165 stock on TipRanks’ Stock Analysis page.

